Chronic Condition Copay Elimination Act

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, The Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation) H.R. 133, the Consolidated Appropriations Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, The Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation) H.R. 133, the Consolidated Appropriations Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, The Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation)

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, The Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation)

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136) H.R. 6800, The Heroes Act H.R. 925, The Heroes Act The HEALS Act (Senate proposed legislation)

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) H.R. 6666, COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act. A bill that provides $100 billion in targeted COVID-19 testing funds to medically underserved communities. (Lobbyists used: Elise Tollefson, Peter Goelz) H.R. 7062, Affordable Insulin for the COVID-19 Emergency Act. A bill that eliminates copays for insulin in Medicare Part D during the COVID-19 national emergency period. (Lobbyists used: Elise Tollefson, Peter Goelz, Matt Scott) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act: The ADA supports this legislation which would address critical health and economic needs for older adults, people with disabilities, front-line workers and family caregivers. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Protecting and strengthening the Affordable Care Act (ACA). The Association supports continued efforts to strengthen and improve the ACA which ensures access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 / S. 3200 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act IRS Notice 2020-15, High Deductible Health Plans and Expenses Related to COVID-19 H.R. 3539, the Telehealth Expansion Act H.R. 6201, Families First Coronavirus Response Act (P.L.116-127) H.R. 748, CARES Act (P.L.116-136)

Client expense: Not reported · Firm income: $90,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Council of Economic Advisers (CEA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

S. 350, Competitive Health Insurance Reform Act (Daines) - McCarran-Ferguson Act S. 455, Marketing and Outreach Restoration to Empower Health Education Act (Shaheen) - funding for outreach and education on ACA Exchanges S. 466, Protecting Americans with Preexisting Conditions Act (Warner) - blocking updated Section 1332 guidance S. 560, Ensuring Lasting Smiles Act (Baldwin) - coverage mandate for treatment of congenital anomaly or birth defect S. 741, Cancer Drug Parity Act (Smith) -- cost sharing for oral anticancer drugs S. 913, Disclosure of Price Information to Enrollees (Braun) S. 961, Improving Health Insurance Affordability Act (Shaheen) - premium tax credits S. 964, Marketplace Certainty Act (Shaheen) - cost-sharing subsidies S. 967, Reducing Costs for Out-of-Network Services Act (Shaheen) - caps on out-of-network charges S. 981, Medicare-X Choice Act (Bennet) - public option S. 1033, CHOICE Act (Whitehouse) - public option S. 1125, Protect Act (Tillis) - pre-existing condition protections S. 1129, Medicare for All Act (Sanders) - government health insurance system S. 1170, Association Health Plans Act (Enzi) - codifying final rule for expanding AHPs S. 1266, Protecting Patients from Surprise Medical Bills Act (Scott) - surprise medical billing S. 1531, STOP Surprise Medical Bills Act (Cassidy-Bennet) - surprise medical billing S. 1576, Behavioral Health Coverage Transparency Act (Warren) - mental health parity S. 1577, Know the Price Act (Cassidy-Bennet) - restrictions on provider contracts S. 1737, Mental Health Parity Compliance Act (Murphy) - mental health parity S. 1948, Chronic Disease Management Act (Thune) - pre-deductible coverage of chronic disease prevention services S. 2546, Safe Step Act (Murkowski)-Step therapy exceptions H.R. 692, Pre-existing Conditions Protection Act (Walden) - pre-existing condition protections H.R. 986, Protecting Americans with Preexisting Conditions Act (Kuster) - blocking updated Section 1332 guidance H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act (Blunt Rochester) - funding for outreach and education on ACA Exchanges, Navigator program, and establishment of state-based Health Insurance Exchanges; drug pricing proposals H.R. 1010, Short-Term Plans (Castor) - blocking final rule that expands short-term plans H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act (Eshoo) - standardized disclosures for short-term plans H.R. 1379, Ensuring Lasting Smiles Act (Peterson) - coverage mandate for treatment of congenital anomaly or birth defect H.R. 1384, Medicare for All Act (Jayapal) - government health insurance system H.R. 1385, State Allowance for a Variety of Exchanges Act (Kim) - funding for establishment of state-based Health Insurance Exchanges H.R. 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act (Castor) - funding for Navigator Program H.R. 1418, Competitive Health Insurance Reform Act (DeFazio) - McCarran-Ferguson Act H.R. 1425, State Health Care Premium Reduction Act (Craig) - funding for state reinsurance programs H.R. 1510, Premium Relief Act (Burgess) -- Patient and State Stability Fund H.R. 1730, Cancer Drug Parity Act (Higgins) -- cost sharing for oral anticancer drugs H.R. 1884, Protecting Pre-Existing Conditions and Making Health Care More Affordable Act (Pallone) - reinsurance funding, stabilization and affordability proposals H.R. 2000, Medicare-X Choice Act (Delgado) - public option H.R. 2061, Pathway to Universal Coverage Act (Bera) - auto-enrollment H.R. 2085, CHOICE Act (Schakowsky) - public option H.R. 2183, State Flexibility and Patient Choice Act (Marshall) - flexibility in state innovation waivers H.R. 2848, Parity Enforcement Act (Norcross) - mental health parity H.R. 2874, Behavioral Health Coverage Transparency Act (Kennedy) - mental health parity H.R. 3165, Mental Health Parity Compliance Act (Porter) - mental health parity H.R. 3502, Protecting People From Surprise Medical Bills Act (Ruiz) - surprise medical billing H.R. 3630, No Surprises Act (Pallone)-surprise medical billing H.R. 3784, Air Ambulance Affordability Act of 2019 (Neguse)- air ambulances H.R. 4223, Protecting Patients from Surprise Medical Bills Act (Spano)-surprise medical billing H.R. 4379, Under Performing Directories that Affect Treating Emergencies Act (Axne)-provider directories H.R. 4457, Chronic Condition Copay Elimination Act (Underwood)- Eliminating copays for services/drugs for chronic conditions H.R. 4484, Flexibility Through Lower Expenses Health Care Act (Budd)-STLDI plans H.R. 4530, Native American Health Savings Improvement Act (Moolenaar)-HSAs H.R. 4575, Improving Provider Directories Act (Schrier)-provider directories H.R. 5010, State-Based Universal Health Care Act of 2019 (Khanna) - universal health care systems H.R. 5121, Healthcare Cost Transparency Act (Beyer) - provider price comparison tool H.R. 5144, Insurance Accountability and Transparency Act (Davids) - insurance have publicly accessible self-audit information H.R. 5239 Prescription Drug Price Reporting Act (Joyce) - reporting on drug expenditures and price changes under group health plans H. Res. 271 (Allred) - resolution urging DOJ to reverse position in Texas v. United States litigation Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

H.R. 1840/S. 814, the Expanding Access to Diabetes Self-Management Training (DSMT) Act. The Association supports this legislation to reduce barriers and increase the utilization of DSMT, which is a covered benefit under Medicare. (Lobbyists Used: Meghan Riley, Robert Goldsmith, Gwen Rathbun, Deema Tarazi) S. 1895, the Lower Health Care Costs Act. Includes 5-year reauthorization of the Special Diabetes Program (SDP), a provision that would end surprise medical billing, and provisions lowering prescription drug costs, which ADA supports. (Lobbyists used: Gwen Rathbun, Robert Goldsmith, Meghan Riley, Deema Tarazi) S.2302, The Americas Transportation Infrastructure Act. Support including provisions for transportation alternative programs, which were included in S.1098 and safe routes to school. (Lobbyist used: Deema Tarazi, Meghan Riley) S.2358, The Wise Investment in Children Act of 2019 (WIC Act). Support extending child eligibility to age six or the beginning of kindergarten; extending infant certification periods to two years; and extending postpartum womens eligibility to two years. (Lobbyist used: Deema Tarazi, Meghan Riley) S. 2199/H.R. 4906, The Insulin Price Reduction Act. The ADA supports this legislation which encourages lower insulin prices. (Lobbyists used: Meghan Riley, Rob Goldsmith) H.R. 2279, the Safe Step Act. The ADA supports this legislation which would require group health plans to provide an exceptions process for any medication step therapy protocol. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 4457, the Chronic Copay Elimination Act. The ADA supports this legislation which will require private health plans to cover preventive services, including screenings and certain medications, with no cost-sharing for people with chronic conditions such as diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) HR 3, the Lower Drug Costs Now Act. This bill would require the HHS Secretary to negotiate prices for certain drugs including insulin. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) S. 2543, the Prescription Drug Pricing Reduction Act. This bill aims to lower the cost of prescription drugs in the Medicare and Medicaid programs and to improve drug pricing transparency. The ADA has not endorsed this legislation but does support specific provisions of this bill. (Lobbyists used: Rob Goldsmith, Meghan Riley) Issues worked on not yet reflected in legislation: Improving access to affordable and adequate health care. The ADA supports continued efforts to protect and expand benefits under the Affordable Care Act (ACA), Medicare, Medicaid, and other health plans to ensure access to affordable health coverage for people with diabetes. (Lobbyists used: Meghan Riley, Rob Goldsmith) Medicare Diabetes Prevention Program. The Association supports efforts to make CDC-recognized virtual diabetes prevention program (DPP) providers eligible for reimbursement in MDPP. (Lobbyists used: Rob Goldsmith, Meghan Riley) Child Nutrition Reauthorization. The Association supports protecting many programs (Summer Meals, School Breakfast Program, WIC) that are a part of the Healthy and Hunger-Free Kids Act, which was last reauthorized in 2010. (Lobbyists used: Deema Tarazi, Meghan Riley)

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1865, Further Consolidated Appropriations Act, 2020

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1865, Further Consolidated Appropriations Act, 2020

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act Executive Order on Protecting and Improving Medicare for Our Nations Seniors H.R. 4716, The Inhaler Coverage and Access Now (I CAN) Act H.R. 1865, Further Consolidated Appropriations Act, 2020

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

S. 350, Competitive Health Insurance Reform Act (Daines) - McCarran-Ferguson Act S. 455, Marketing and Outreach Restoration to Empower Health Education Act (Shaheen) - funding for outreach and education on ACA Exchanges S. 466, Protecting Americans with Preexisting Conditions Act (Warner) - blocking updated Section 1332 guidance S. 560, Ensuring Lasting Smiles Act (Baldwin) - coverage mandate for treatment of congenital anomaly or birth defect S. 741, Cancer Drug Parity Act (Smith) -- cost sharing for oral anticancer drugs S. 913, Disclosure of Price Information to Enrollees (Braun) S. 961, Improving Health Insurance Affordability Act (Shaheen) - premium tax credits S. 964, Marketplace Certainty Act (Shaheen) - cost-sharing subsidies S. 967, Reducing Costs for Out-of-Network Services Act (Shaheen) - caps on out-of-network charges S. 981, Medicare-X Choice Act (Bennet) - public option S. 1033, CHOICE Act (Whitehouse) - public option S. 1125, Protect Act (Tillis) - pre-existing condition protections S. 1129, Medicare for All Act (Sanders) - government health insurance system S. 1170, Association Health Plans Act (Enzi) - codifying final rule for expanding AHPs S. 1266, Protecting Patients from Surprise Medical Bills Act (Scott) - surprise medical billing S. 1531, STOP Surprise Medical Bills Act (Cassidy-Bennet) - surprise medical billing S. 1576, Behavioral Health Coverage Transparency Act (Warren) - mental health parity S. 1577, Know the Price Act (Cassidy-Bennet) - restrictions on provider contracts S. 1737, Mental Health Parity Compliance Act (Murphy) - mental health parity S. 1948, Chronic Disease Management Act (Thune) - pre-deductible coverage of chronic disease prevention services S. 2546, Safe Step Act (Murkowski)-Step therapy exceptions H.R. 692, Pre-existing Conditions Protection Act (Walden) - pre-existing condition protections H.R. 986, Protecting Americans with Preexisting Conditions Act (Kuster) - blocking updated Section 1332 guidance H.R. 987, Marketing and Outreach Restoration to Empower Health Education Act (Blunt Rochester) - funding for outreach and education on ACA Exchanges, Navigator program, and establishment of state-based Health Insurance Exchanges; drug pricing proposals H.R. 1010, Short-Term Plans (Castor) - blocking final rule that expands short-term plans H.R. 1143, Educating Consumers on the Risks of Short-Term Plans Act (Eshoo) - standardized disclosures for short-term plans H.R. 1379, Ensuring Lasting Smiles Act (Peterson) - coverage mandate for treatment of congenital anomaly or birth defect H.R. 1384, Medicare for All Act (Jayapal) - government health insurance system H.R. 1385, State Allowance for a Variety of Exchanges Act (Kim) - funding for establishment of state-based Health Insurance Exchanges H.R. 1386, Expand Navigators Resources for Outreach, Learning, and Longevity Act (Castor) - funding for Navigator Program H.R. 1418, Competitive Health Insurance Reform Act (DeFazio) - McCarran-Ferguson Act H.R. 1425, State Health Care Premium Reduction Act (Craig) - funding for state reinsurance programs H.R. 1510, Premium Relief Act (Burgess) -- Patient and State Stability Fund H.R. 1730, Cancer Drug Parity Act (Higgins) -- cost sharing for oral anticancer drugs H.R. 1884, Protecting Pre-Existing Conditions and Making Health Care More Affordable Act (Pallone) - reinsurance funding, stabilization and affordability proposals H.R. 2000, Medicare-X Choice Act (Delgado) - public option H.R. 2061, Pathway to Universal Coverage Act (Bera) - auto-enrollment H.R. 2085, CHOICE Act (Schakowsky) - public option H.R. 2183, State Flexibility and Patient Choice Act (Marshall) - flexibility in state innovation waivers H.R. 2848, Parity Enforcement Act (Norcross) - mental health parity H.R. 2874, Behavioral Health Coverage Transparency Act (Kennedy) - mental health parity H.R. 3165, Mental Health Parity Compliance Act (Porter) - mental health parity H.R. 3502, Protecting People From Surprise Medical Bills Act (Ruiz) - surprise medical billing Discussion Draft, No Surprises Act (Pallone-Walden) - surprise medical billing H.R. 3630, No Surprises Act (Pallone)-surprise medical billing H.R. 3784, Air Ambulance Affordability Act of 2019 (Neguse)- air ambulances H.R. 4223, Protecting Patients from Surprise Medical Bills Act (Spano)-surprise medical billing H.R. 4379, Under Performing Directories that Affect Treating Emergencies Act (Axne)-provider directories H.R. 4457, Chronic Condition Copay Elimination Act (Underwood)- Eliminating copays for services/drugs for chronic conditions H.R. 4484, Flexibility Through Lower Expenses Health Care Act (Budd)-STLDI plans H.R. 4530, Native American Health Savings Improvement Act (Moolenaar)-HSAs H.R. 4575, Improving Provider Directories Act (Schrier)-provider directories H. Res. 271 (Allred) - resolution urging DOJ to reverse position in Texas v. United States litigation Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; pre-existing condition insurance plans; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

Legislative and regulatory issues including: improvements to Health Savings Accounts coupled with high deductible health plans, Medicare and Medicare Advantage, low-value care, and payment reform. Chronic Disease Management Act -- S. 1948 / H.R. 3709 Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First, published June 24, 2019 Treasury Notice 2019-45, Additional Preventive Care Benefits Permitted to be Provided by a High Deductible Health Plan Under 223 S. 2543, the Prescription Drug Pricing Reduction Act of 2019 H.R. 4457, the Chronic Condition Copay Elimination Act

Client expense: Not reported · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Economic Council (NEC), SENATE, Treasury, Dept of

H.R. 3222 No Federal Funds for Public Charge Act of 2019 - no Federal funds may be used to carry out the proposed rule of the Department of Homeland Security entitled Inadmissibility on Public Charge Grounds H.R.1897 MOMMA's Act - Federal efforts with respect to the prevention of maternal mortality H.R.2115 Public Disclosure of Drug Discounts Act - legislation to provide greater transparency of discounts provided by drug manufacturers. S.340/H.R.965CREATES - facilitate the timely entry of lower-cost generic and biosimilar versions of drugs and biological products H.R. 938 the Bringing Low-cost Options and Competition while Keeping Incentives for New Generics (BLOCKING) Act of 2019 - eligibility for FDA approval of a subsequent generic drug, to remove the barrier to that approval posed by the 180-day exclusivity period afforded to a first generic applicant that has not yet received final approval H.R. 1499, the Protecting Consumer Access to Generic Drugs Act of 2019 - pay for delay; prohibit brand name drug manufacturers from compensating generic drug manufacturers to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable product manufacturers to delay entry of biosimilar and interchangeable products H.R.2113 Prescription Drug STAR Act - require drug manufacturer price transparency, to require certain manufacturers to report on product samples provided to certain health care providers, H.R.2296, S.1391 FAIR Drug Pricing Act - Rx pricing transparency, require manufacturers to justify price increases H.R.2376, S.1227 Prescription Pricing for the People Act - directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain S.Res.134 - A resolution expressing the sense of the Senate that the Department of Justice should reverse its position in Texas v. United States, No. 4:18-cv-00167-O (N.D. Tex.) H.R.1010 - To provide that the rule entitled "Short-Term, Limited Duration Insurance" shall have no force or effect H.R.1868 - Health Care Affordability Act of 2019 - reducing insurance premiums and out-of-pocket costs in the individual and small group markets, both for low-income families and those that are not eligible for tax credits H.R.1425 State Health Care Premium Reduction Act - Improve Health Insurance Affordability Fund to provide for certain reinsurance payments to lower premiums in the individual health insurance market H.R.986 - Protecting Americans with Preexisting Conditions Act of 2019 - certain guidance related to waivers for State innovation under the Patient Protection and Affordable Care Act shall have no force or effect H.R.987Strengthening Health Care and Lowering Prescription Drug Costs Ac- requires the Department of Health and Human Services (HHS) to conduct outreach and educational activities regarding federally-facilitated exchanges (i.e., health insurance exchanges that are established and operated within states by HHS). The activities must inform potential enrollees of the availability of coverage and related financial assistance under the exchanges and must be provided in culturally and linguistically appropriate formats. S.1556No Junk Plans Act - rule entitled Short-Term, Limited Duration Insurance shall have no force or effect. S.1531STOP Surprise Medical Bills Act - provide protections for health insurance consumers from surprise billing H.R.861 - End Surprise Billing Act of 2019 - prevent surprise billing practices and require notification for consumers S.1895 Lower Health Care Costs Act - comprehensive legislation to end surprise medical bills, reduce prescription drug prices, improve health care transparency, improve public health, improve exchange of health information H.R. 3630 No Surprises Act - legislation to protect consumers from surprise medical bills, using median in network rate and an option to go to arbitration for bills above $1250. H.R. 3502 Protecting People From Surprise Medical Bills Act - legislation to protect consumers from surprise medical bills, arbitration as payment mechanism H.R.748, S. 684Middle Class Health Benefits Tax Repeal Act of 2019 - repeal the excise tax on high value employer-sponsored health care coverage, also known as the Cadillac Tax S. 1801 Affordable Medications Act - increase drug price transparency and affordability, spur innovation, and enhance competition S.455/ H.R.987 - MORE Health Education Act - funding for Federal Exchange outreach and educational activities H.R.3180, S. 1770 RISE (Resilience Investment, Support, and Expansion) from Trauma Act - improve the identification and support of children and families who experience trauma S.2387 We Protect American Investment in Drugs Act - prohibits Pharmaceutical companies developing prescription drugs using federally-funded research, like NIH or CDC grants, from charging American consumers unreasonable prices for life-saving drugs H.R.2411/S.1258 Tobacco to 21 Act - prohibit the sale of tobacco products to individuals under the age of 21 H.R.2339 Reversing the Youth Tobacco Epidemic Act - legislation to curb the rise of youth tobacco use H.R. 4548 Asthma Care and Prevention in Rural Communities Act -authorize CDC to award grants to eligible counties for the use of mobile clinics and distance learning and telemedicine to diagnose and treat children with asthma in rural areas and medically underserved communities, H.R.4158 CURE High Drug Prices Act - prohibit price gouging in the sale of drugs H.R.4575 - Improving Provider Directories Act - require group health plans and health insurance issuers offering group or individual health insurance coverage to establish a process to address inaccurate information listed in publicly accessible provider directories of such plans and issuers H.R. 4457 Chronic Condition Copay Elimination Act - require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for additional preventive care for individuals with chronic conditions without the imposition of cost sharing requirement H.R.2374 Stop STALLING Act - enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns H.R.1983 Community Health Investment, Modernization, and Excellence Act of 2019 - reauthorize and extend funding for community health centers and the National Health Service Corp Legislation to prevent air ambulances from balance billing patients Legislation to require health care facilities and providers to give patients a list of services received upon discharge Legislation to reauthorize the Patient-Centered Outcomes Research Institute (PCORI)